Healthcare Industry News:  Palomar Medical Technologies 

Devices Personnel

 News Release - March 10, 2008

Candela Names Robert LaRoche Vice President of Global Marketing

WAYLAND, Mass.--(HSMN NewsFeed)--Candela Corporation (NASDAQ: CLZR ) announced today that Robert LaRoche has joined the company as Vice President of Global Marketing. Mr. LaRoche will lead Candela’s worldwide marketing efforts of current products and pipeline product opportunities.

“With over 25 years of medical device marketing and sales experience, Bob is a proven leader in the medical device marketplace. We are confident that he will apply his unique skill set and insight to drive sales revenues and increase global awareness of Candela’s products,” said Jay Caplan, Chief Operating Officer.

Most recently, Mr. LaRoche served as Vice President of Marketing and Sales at InfraReDx, Inc., a Burlington, Massachusetts-based medical device start-up, where he led the marketing and sales development process for the company’s first commercialized product. Prior to that, he was Founder and President of Octant Marketing Inc., a consultancy serving the medical products industry, and has also held various managerial marketing positions.

Mr. LaRoche earned a Bachelor’s degree in Marine Fisheries Biology from the University of Massachusetts Amherst.

About CANDELA: Candela Corporation manufactures, and distributes innovative clinical solutions that enable physicians, surgeons, and personal care practitioners to treat selected cosmetic and medical conditions using lasers, aesthetic laser systems, and other advanced technologies. Founded near Boston in 1970, the company markets and services its products in over 70 countries from offices and distributors in the United States, Europe, Japan, China and other Asian locations. Candela established the aesthetic laser market 18 years ago, and currently has an installed base of an estimated 12,000 lasers worldwide. Visit Candela on the Web at

Safe Harbor Statement: Except for the historical information contained herein, this news release contains forward-looking statements that constitute Candela's current intentions, hopes, beliefs, expectations or predictions of the future, which are therefore inherently subject to risks and uncertainties. Such statements may relate to, among other things, our future revenue, gross margin, expense levels and earnings, our growth prospects, market acceptance of our products, the strength of our distribution channels, our ability to add new products, our ability to expand regulatory approvals and the liquidity of our common stock. The risks and uncertainties that may affect forward-looking statements include, among others: the cancellation or deferral of customer orders, the risk of an adverse judgment in the patent litigation with Palomar Medical Technologies, Inc., dependence on a small number of strategic distribution relationships, difficulties in the timely development and market acceptance of new products, unanticipated increases in expenses, market developments that vary from the current public expectations concerning the growth of the laser industry, increased competitive pressures, changes in economic conditions, or difficulties in obtaining timely regulatory approvals. Further information on factors that could affect Candela's performance is included in Candela's periodic reports filed with the SEC. Candela cautions readers not to place undue reliance upon any such forward-looking statements, which speak only as of the date made. Candela expressly disclaims any obligations or undertaking to release publicly any updates or revisions to any such statements to reflect any change in Candela's expectations or any change in events, conditions or circumstances on which any such statement is based.

Source: Candela

Issuer of this News Release is solely responsible for its content.
Please address inquiries directly to the issuing company.

FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.